Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.
复制标题
过氧化物酶体增殖物激活受体γ (PPARγ):中枢神经系统损伤和修复的主要看门人
DOI:
10.1016/j.pneurobio.2017.10.002
复制
发表时间:
2018-04
影响因子:
6.7
通讯作者:
Chen J
中科院分区:
文献类型:
--
作者:
Cai W;Yang T;Liu H;Han L;Zhang K;Hu X;Zhang X;Yin KJ;Gao Y;Bennett MVL;Leak RK;Chen J
Peroxisome proliferator-activated receptor γ (PPARγ) is a widely expressed ligand-modulated transcription factor that governs the expression of genes involved in inflammation, redox equilibrium, trophic factor production, insulin sensitivity, and the metabolism of lipids and glucose. Synthetic PPARγ agonists (e.g. thiazolidinediones) are used to treat Type II diabetes and have the potential to limit the risk of developing brain injuries, such as stroke, by mitigating the influence of comorbidities. If brain injury develops, PPARγ serves as a master gatekeeper of cytoprotective stress responses, improving the chances of cellular survival and recovery of homeostatic equilibrium. In the acute injury phase, PPARγ directly restricts tissue damage by inhibiting the NFκB pathway to mitigate inflammation and stimulating the Nrf2/ARE axis to neutralize oxidative stress. During the chronic phase of acute brain injuries, PPARγ activation in injured cells culminates in the repair of gray and white matter, preservation of the blood-brain barrier, reconstruction of the neurovascular unit, resolution of inflammation, and long-term functional recovery. Thus, PPARγ lies at the apex of cell fate decisions and exerts profound effects on the chronic progression of acute injury conditions. Here, we review the therapeutic potential of PPARγ in stroke and brain trauma and highlight the novel role of PPARγ in long-term tissue repair. We describe its structure and function and identify the genes that it targets. PPARγ regulation of inflammation, metabolism, cell fate (proliferation/differentiation/maturation/survival), and many other processes also has relevance to other neurological diseases. Therefore, PPARγ is an attractive target for therapies against a number of progressive neurological disorders.
登录
查看更多内容
DOI:
10.1161/atvbaha.112.300962
发表时间:
2013-04-01
影响因子:
8.7
作者:
Auclair, Martine;Vigouroux, Corinne;Caron-Debarle, Martine
通讯作者:
Caron-Debarle, Martine
影响因子:
6.7
作者:
Bath, Philip M.;Appleton, Jason P.;Sprigg, Nikola
通讯作者:
Sprigg, Nikola
影响因子:
3.3
作者:
Bauer, S;Hay, M;Moyse, E
通讯作者:
Moyse, E
DOI:
10.1007/s003290050147
发表时间:
1999-09-01
期刊:
CRITICAL REVIEWS IN NEUROSURGERY
影响因子:
--
作者:
Asano, T
通讯作者:
Asano, T
影响因子:
82.9
作者:
通讯作者:
--